Diabetic cardiomyopathy

Heart Failure Clinics

Volumn 2, Issue 1, 2006, Pages 71-80

  Vaughan, T Brooks ^a   Bell, David S H ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b FOT ^*

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADVANCED GLYCATION END PRODUCT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; INSULIN SENSITIZING AGENT; METFORMIN; MURAGLITAZAR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; TRIENTINE;

ASCITES; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE; CARDIOMYOPATHY; CLINICAL TRIAL; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; ECHOCARDIOGRAPHY; GLUCOSE BLOOD LEVEL; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LUNG EDEMA; METABOLIC DISORDER; MICROANGIOPATHY; NONHUMAN; PERIPHERAL EDEMA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR; SCREENING; SYMPATHETIC TONE;

CARDIOMYOPATHIES; COMORBIDITY; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; PREVALENCE; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 33644902943     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2005.11.001     Document Type: Review

References (79)

1. W.B. Kannel, and D.L. McGee Diabetes and cardiovascular disease: the Framingham study JAMA 241 1979 2035 2038
2. G.A. Nichols, T.A. Hillier, and J.R. Erbey Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors Diabetes Care 24 2001 1614 1619
3. W.S. Aronow, and C. Ahn Incidence of heart failure in 2737 older persons with and without diabetes mellitus Chest 115 1999 867 868
4. L. Amato, G. Paolisso, and F. Cacciatore Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly: the Osservatorio Geriatrico Regione Campania Group Diabetes Metab 23 1997 213 218
5. A. Mazza, V. Tikhonoff, and E. Casiglia Predictors of congestive heart failure mortality in elderly people from the general population Int Heart J 46 2004 419 431
6. S.E. Reis, R. Holubkov, and D. Edmundowicz Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes J Am Coll Cardiol 30 1997 733 738
7. G. Fonarow Approach to the management of diabetic patients with heart failure: role of thiazolidinediones Am Heart J 148 2004 551 558
8. D.S.H. Bell, and F. Ovalle Frequency of diabetes in patents admitted to the hospital because of congestive heart failure [abstract] Diabetes 50 2001 A456
9. A. Tenenbaum, E.Z. Fisman, and Y. Adler Functional class in patients with heart failure is associated with the development of diabetes Am J Med 114 2003 271 275
10. S.M. Grundy Higher incidence of new-onset diabetes in patients with heart failure Am J Med 114 2003 331 332
11. S. Rubler, J. Dlugash, and Y.Z. Yuceoglu New type of cardiomyopathy associated with diabetic glomerulosclerosis Am J Cardiol 30 1972 595 602
12. S.S. Coughlin, D.L. Pearle, and K.L. Baughman Diabetes mellitus and risk of idiopathic dilated cardiomyopathy Ann Epidemiol 4 1994 67 74
13. A.G. Bertoni, E.K. Kasper, and A. Tsai Diabetes and idiopathic cardiomyopathy: a nationwide case-control study Diabetes Care 26 2003 2791 2795
14. D.W. Sohn, I.H. Chai, and D.J. Lee Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function J Am Coll Cardiol 30 1997 595 602
15. C.M. Schwannwell, M. Scheppenheim, and S. Perings Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy Cardiology 98 2002 33 39
16. B. Suys, N. Katier, and R.P.A. Rooman Female children and adolescents with type 1 diabetes have more pronounced early echocardiographic signs of diabetic cardiomyopathy Diabetes Care 27 2004 1947 1953
17. A. Nicolino, G. Longobardi, and G. Furgi Left ventricular diastolic filling in diabetes mellitus with and without hypertension Am J Hypertens 8 1995 382 389
18. P. Di Bonito, S. Cuomo, and N. Moio Diastolic dysfunction in patients with non-insulin-dependent diabetes mellitus of short duration Diabet Med 13 1996 321 324
19. M.M. Redfield, S.J. Jacobsen, and J.C. Burnett Jr Burden of systolic and diastolic dysfunction in the community JAMA 289 2003 194 202
20. P. Poirier, P. Bogaty, and C. Garneau Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy Diabetes Care 24 2001 5 10
21. N.E. Friedman, L.L. Levisky, and D.V. Edidin Echocardiographic evidence for impaired myocardial performance in children with type 1 diabetes mellitus Am J Med 73 1982 846 850
22. J.C. Mbanya, E. Sobngwi, and D.S. Mbanya Left ventricular mass and systolic function in African diabetic patients: association with microalbuminuria Diabetes Metab 27 2001 378 382
23. Z.Y. Fang, S. Yuda, and V. Anderson Echocardiographic detection of early diabetic myocardial disease J Am Coll Cardiol 41 2003 611 617
24. C. Iribarren, A.J. Karter, and A.S. Go Glycemic control and heart failure among adult patients with diabetes Circulation 103 2001 2668 2673
25. 1c to left ventricular relaxation in patients with type 1 diabetes mellitus and without overt heart disease Am J Cardiol 91 2003 1514 1517
26. R.B. Devereux, M.J. Roman, and M. Paranicas Impact of diabetes on cardiac structure and function: the Strong Heart Study Circulation 101 2000 2271 2276
27. M. Cooper Importance of advanced glycation end products in diabetes associated cardiovascular and renal disease Am J Hypertens 17 2004 31S 38S
28. R. Candido, J.M. Forbes, and M.C. Thomas A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes Circ Res 92 2003 785 792
29. S. Nunoda, A. Genda, and N. Sugihara Quantitative approach to the histopathology of the biopsied right ventricular myocardium in patients with diabetes mellitus Heart Vessels 1 1985 43 47
30. E. Picano, G. Pelosi, and M. Marzilli In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans Circulation 81 1990 58 64
31. F. Gonzalez-Vilchez, J. Ayuela, and M. Ares Oxidative stress and fibrosis in incipient myocardial dysfunction in type 2 diabetic patients Int J Cardiol 101 2003 53 58
32. I. Waczulikova, A. Ziegelhoffer, and Z. Orszaghova Fluidising effect of resrcylidene aminoguanidine on sarcolemmal membranes in streptozotocin-diabetic rats: blunted adaptation of diabetic myocardium to Ca overload J Physiol Pharmacol 53 2002 727 739
33. S. Garcia, L. Virag, and P. Jagtap Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation Nat Med 7 2001 108 113
34. C. Szabo Roles of poly(ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications Pharmacol Res 52 2005 60 71
35. M.F. Oliver, and L.H. Opie Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias Lancet 343 1994 155 158
36. O.D. Mjos Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs J Clin Invest 50 1991 1386 1389
37. Y.T. Zhou, P. Grayburn, and A. Karim Lipotoxic heart disease in obese rats: implications for human obesity Proc Natl Acad Sci USA 97 4 2000 1784 1789
38. M.E. Young, F. Laws, and G.W. Goodwin Reactivation of peroxisome proliferators-activator receptor α is associated with contractile dysfunction in hypertrophied rat heart J Biol Chem 276 2001 44390 44395
39. B. Finck, J. Lehman, and T. Leone The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus J Clin Invest 109 2002 121 130
40. G.J.S. Cooper, A.R.J. Phillips, and S.Y. Choong Regeneration of the heart in diabetes by selective copper chelation Diabetes 53 2004 2501 2508
41. G.J.S. Cooper, Y.K. Chan, and A.M. Dissanayake Demonstration of a hyperglycemia-driven pathogenic abnormality of copper homeostasis in diabetes and its reversibility by selective chelation Diabetes 54 2005 1468 1476
42. H. Wakasaki, D. Koya, and F. Schoen Targeted overexpression of protein kinase C B2 isoform in myocardium causes cardiomyopathy Proc Natl Acad Sci USA 94 1997 9320 9325
43. M.E. Young, P. McNulty, and H. Tegtemeyer Adaptation and maladaptation of the heart in diabetes: part II, potential mechanisms Circulation 105 2002 1861 1870
44. M. Bristow Etomoxir: a new approach to treatment of chronic heart failure Lancet 356 2000 1621 1622
45. A. Genda, S. Mizuno, and S. Nunoda Clinical studies on diabetic myocardial disease using exercise testing with myocardial scintigraphy and endomyocardial biopsy Clin Cardiol 9 1986 375 382
46. S. Sunni, S.P. Bishop, and S.P. Kent Diabetic cardiomyopathy: a morphological study of intramyocardial arteries Arch Pathol Lab Med 110 1986 375 381
47. R. Yarom, H. Zirkin, and G. Stammler Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material J Pathol 166 3 1992 265 270
48. Y. Yoon, S. Uchida, and O. Masuo Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy Circulation 111 2004 2073 2085
49. A.I. Vinik, R.E. Maser, and B.D. Mitchell Diabetic autonomic neuropathy Diabetes Care 26 5 2003 1553 1579
50. R.E. Maser, and M.J. Lenhard Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences and treatment J Clin Endocrinol Metab 90 10 2005 5896 5903
51. Z.Y. Fang, J.B. Prins, and T. Marwick Diabetic cardiomyopathy: evidence, mechanisms and therapeutic implications Endocr Rev 25 4 2004 543 567
52. G. Kreiner, M. Wolzt, and P. Fasching Myocardial M(123-I) iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Comparison with cardiovascular reflex tests and relationship to left ventricular function Diabetes 44 1995 543 549
53. M. Taskiran, T. Fritz-Hansen, and V. Rasmussen Decreased myocardial perfusion reserve in diabetic autonomic neuropathy Diabetes 51 2002 3306 3310
54. M.R. Bristow Why does the myocardium fail? Insights from basic science Lancet 352 Suppl 1 1998 SI8 SI14
55. E.J. Eichhorn, and M.R. Bristow Medical therapy can improve the biological properties of the chronically failing heart: a new erea in the treatment of hear failure Circulation 94 1996 2285 2296
56. T.A. McDonagh, C.E. Morrison, and A. Lawrence Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population Lancet 350 1999 829 833
57. P.H. Stone, D.S. Raabe, and A.S. Jaffe Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location J Am Coll Cardiol 11 1988 453 463
58. D. Levy, M.G. Larson, and R.S. Vasan The progression from hypertension to congestive heart failure JAMA 275 1996 1557 1562
59. S.A. Hunt, D.W. Baker, and M.H. Chin ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) J Am Coll Cardiol 38 2001 2101 2113
60. Joint National Committee on Prevention DEaToHBP The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Arch Intern Med 157 1997 2413 2446
61. A.I. Adler, I.M. Stratton, and H.A.W. Neil Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study BMJ 321 2000 412 419
62. P.R. Marantz, J.N. Tobin, and S. Wassertheil-Smoller The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria Circulation 77 1988 607 612
63. V. Bittner, D.H. Weiner, and S. Yusuf Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction: SOLVD investigators JAMA 270 1993 1702 1707
64. M.G. Bourassa, O. Gurne, and S.I. Bangdiwala Natural history and patterns of current practice in heart failure: the Studies of Left Ventricular Dysfunction (SOLVD) investigators J Am Coll Cardiol 22 1993 14A 19A
65. A.D. Struthers, and A.D. Morris Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths Lancet 359 2002 1430 1432
66. J.G. Lainchbury, and M.M. Redfield Doppler echocardiographic-guided diagnosis and therapy of heart failure Curr Cardiol Rep 1 1999 55 66
67. K. McKenna, D. Smith, and W. Tormey Acute hyperglycaemia causes elevation in plasma atrial natriuretic peptide concentrations in type 1 diabetes mellitus Diabet Med 17 2000 512 517
68. T.A. McDonagh, S.D. Robb, and D.R. Murdoch Biochemical detection of left-ventricular systolic dysfunction Lancet 351 1998 9 13
69. J.E. Liu, D.C. Robbins, and V. Palmieri Association of microalbuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study J Am Coll Cardiol 42 2003 2022 2028
70. J.M. Arnold, S. Yusuf, and J. Young Prevention of heart failure in patients in the Heart Outcome Prevention Evaluation (HOPE) study Circulation 107 2003 1284 1290
71. United Kingdom Prospective Diabetes Study (UKPDS) Group Investigators Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ 317 1998 703 713
72. United Kingdom Prospective Diabetes Study (UKPDS) Group Investigators Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 BMJ 317 1998 713 720
73. W.H. Tang, G.S. Francis, and B.J. Hoogwerf Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure J Am Coll Cardiol 41 2003 1394 1398
74. M. St. John Sutton, M. Rendell, and P. Dandona A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes Diabetes Care 25 2002 2058 2064
75. R.L. Schneider, S.J. Shaffer for the Pioglitazone 011 Study Group Long-term echocardiographic assessment in patients with type 2 diabetes mellitus Circulation 106 2002 679 684
76. C.H. Wang, R.D. Weisel, and P.P. Liu Glitazones and heart failure: critical appraisal for the clinician Circulation 107 2003 1350 1354
77. F.A. Masoudi, S.E. Inzucchi, and Y. Wang Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study Circulation 111 2005 583 590
78. S.E. Nissen, K. Wolski, and E.J. Topol Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus JAMA 294 2005 2581 2586
79. J.M. Brophy Selling safety-lessons from muraglitazar JAMA 294 2005 2633 2635